[{"NetIncomeLoss_1_Q1_USD":-99714000.0,"Liabilities_0_Q1_USD":225366000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-400000.0,"ContractWithCustomerAssetCreditLossExpense_1_Q1_USD":1582000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":58023000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":86479000.0,"PreferredStockValueOutstanding_0_Q1_USD":null,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-5097000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":132197000.0,"Depreciation_1_Q1_USD":1600000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":755639.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":79477000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":83000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":83080000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":42002000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":102000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":7988000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":8318000.0,"IncomeTaxesPaidNet_1_Q1_USD":574000.0,"CommonStockSharesIssued_0_Q1_shares":58277412.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":732163000.0,"Assets_0_Q1_USD":1625387000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_0_Q1_USD":55.07,"ShareBasedCompensation_1_Q1_USD":20684000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":65987000.0,"AssetsCurrent_0_Q1_USD":937710000.0,"EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_1_Q1_USD":528000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":697966000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-1464000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-185000.0,"IncreaseDecreaseInOtherNoncurrentAssets_1_Q1_USD":44000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":79710000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":66.79,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_0_Q1_USD":169000000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_1_Q1_USD":215450000.0,"ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss_0_Q1_USD":2000000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-97000.0,"InventoryWriteDown_1_Q1_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_0_Q1_shares":3279897.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-20785000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-214000.0,"OtherAssetsNoncurrent_0_Q1_USD":5360000.0,"AccountsReceivableNetCurrent_0_Q1_USD":34662000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q1_USD":578168000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0_Q1_security":12.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_1_Q1_USD":21212000.0,"ContractWithCustomerAssetAllowanceForCreditLossRecovery_1_Q1_USD":774000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":1608000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":7011000.0,"CostsAndExpenses_1_Q1_USD":121814000.0,"RestrictedCash_0_Q1_USD":5200000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q1_USD":1430100000.0,"IncreaseDecreaseInInventories_1_Q1_USD":4837000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_1_Q1_USD":0.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-99597000.0,"CommonStockValue_0_Q1_USD":58000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice_1_Q1_USD":73.23,"RestrictedCashNoncurrent_0_Q1_USD":5171000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":21296000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":117000.0,"OtherOperatingActivitiesCashFlowStatement_1_Q1_USD":536000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":643000.0,"InterestIncomeExpenseNet_1_Q1_USD":738000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":21212000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":517000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-125778000.0,"LiabilitiesCurrent_0_Q1_USD":112437000.0,"AccountsPayableCurrent_0_Q1_USD":2889000.0,"NonoperatingIncomeExpense_1_Q1_USD":524000.0,"CommonStockSharesOutstanding_0_Q1_shares":58277412.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":703137000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":5657000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.082,"SubleaseIncome_1_Q1_USD":327000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_0_Q1_security":0.0,"AdditionalPaidInCapital_0_Q1_USD":2136130000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":257309.0,"OperatingLeasePayments_1_Q1_USD":3696000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":443000.0,"InventoryNoncurrent_0_Q1_USD":1213000.0,"AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_0_Q1_USD":578200000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":32991000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":25856000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":27613000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":13430000.0,"LeaseCost_1_Q1_USD":4395000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":2594000.0,"CommonStockSharesAuthorized_0_Q1_shares":120000000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_1_Q1_USD":0.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":153995000.0,"InventoryNet_0_Q1_USD":16030000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":14876000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":100.26,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":32.31,"OperatingLeaseCost_1_Q1_USD":4722000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":1625387000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":11327000.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":20684000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q1_USD":133200000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod_1_Q1_shares":142578.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":54287000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":8193000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-1.72,"ProfitLoss_1_Q1_USD":-99714000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":7355000.0,"StockholdersEquity_0_Q1_USD":1400021000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":26097000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":173000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":731603000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q1_USD":21576000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":6386393.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-731070000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":11797000.0,"EntityListingParValuePerShare_1_Q1_USD":0.001,"Ticker":"BPMC","CIK":"1597264","name":"BLUEPRINT MEDICINES CORP","OfficialName":"Blueprint Medicines Corporation Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"3980842399.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210429"}]